Article info

PDF

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study

Authors

  1. Correspondence to Dr Fabian Hoti; fabian.hoti{at}epidresearch.com
View Full Text

Citation

Strongman H, Christopher S, Majak M, et al
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study

Publication history

  • Received October 4, 2017
  • Revised November 21, 2017
  • Accepted December 13, 2017
  • First published January 20, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.